Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7634 USD | -6.10% | +2.65% | -62.58% |
Apr. 15 | Nature Medicine Publishes Interim Results from Gritstone Bio's Phase 1/2 Study of "Off-The-Shelf" Neoantigen Vaccine Platform | CI |
Apr. 02 | Top Midday Decliners | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.58% | 86.49M | |
-2.86% | 87.31B | |
+2.63% | 40.86B | |
-21.63% | 29.36B | |
+58.56% | 24.49B | |
-14.57% | 17.31B | |
-18.87% | 11.62B | |
-15.61% | 11.31B | |
-44.02% | 11.26B | |
+5.17% | 8.31B |
- Stock Market
- Equities
- GRTS Stock
- News Gritstone bio, Inc.
- Transcript : Gritstone bio, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-13-2022 08